FDA advisers object to Alzheimer’s drug aducanumab ahead of final decision
By
Alicia Lasek
Apr 05, 2021
The experimental Alzheimer’s drug aducanumab is not ready for federal approval in June, advisers to the Food and Drug Administration say in a new JAMA editorial.
After 20 years on the market, AbbVie’s dry-eye drug Restasis to be available as generic
By
Alicia Lasek
Feb 03, 2022
Dry eyes affect nearly 19% percent of adults aged 75 years and older, according to data from a national survey.
25 percent of COVID patients have post-acute symptoms; Report highlights emerging care needs
By
Alicia Lasek
Jun 18, 2021
A analysis based on nearly two million private U.S. healthcare claims has identified the most common post-COVID conditions with a focus on age, gender, mental health conditions and mortality. Even 19%...
HHS sets national plan to ‘end cancer as we know it’
By
Alicia Lasek
Apr 04, 2023
A new framework sets goals for early detection and prevention; development of effective treatments; eliminating cancer-care related inequalities; and supporting optimal care delivery.
Feds identify promising and ‘urgently needed’ COVID antiviral drug
By
Alicia Lasek
Jun 04, 2021
The experimental drug TEMPOL has shown promise in early studies, halting the activity of a viral enzyme and limiting the severity of SARS-CoV-2 infections.
An antibody cocktail that halts disease progression in sick COVD-19 patients has been shown to prevent the disease altogether in healthy people who live in close contact with an infected person, the drugmaker...
LTC research hub to bring clinical trials to rural residents
By
Alicia Lasek
Sep 16, 2022
Nursing home operator Principle LTC and Care Access, a research organization, have launched a new research hub in Raleigh, NC, to provide rural residents access to clinical trials.
‘No reliable evidence’ for most antidepressants in relief of long-term pain, review finds
By
Alicia Lasek
May 18, 2023
With the exception of duloxetine, there is not enough reliable evidence to support the use of most antidepressant medications in the relief of chronic pain, a new review and meta-analysis has shown.
At-home COVID-19 tests get a $70M boost as feds push to increase access
By
Alicia Lasek
Oct 27, 2021
The Biden Administration is streamlining the process to bring new tests to market among other moves designed to increase testing supplies and access.
CDC says COVID-19 vaccine boosters not yet necessary, while Pfizer seeks approval for third dose
By
Alicia Lasek
Jul 12, 2021
Fully vaccinated Americans do not need a COVID-19 booster shot at this time, according to federal health officials. But Pfizer has asked to offer a third dose of its current vaccine and is developing an...